Recent trends in managing Type 2 Diabetes

Recent advancements in drug discovery have led to the emergence of innovative therapeutics for diabetes treatment. Promising classes of drugs, including Incretin mimetics, Amylin analogues, GIP analogs, Peroxisome proliferator-activated receptors, and dipeptidyl peptidase-4 inhibitors, have been identified as potential targets. Moreover, the exploration of bioactive compounds from plants has revolutionized the search for effective treatments in diabetes management. Exciting technologies such as infrared radiation, Raman spectroscopy, thermal imaging, photoacoustic spectroscopy, and millimeter waves offer the possibility of non-invasive and continuous monitoring of blood glucose levels, eliminating the need for painful finger pricks. Additionally, ongoing research on immunotherapy shows promise in preventing or delaying the onset of Type 1 diabetes, particularly for individuals with a genetic predisposition to the disease. Multiple approaches are being developed, including the utilization of the tuberculosis vaccine, monoclonal antibody development, and synthetic peptide modification. With an increasing number of clinical studies, the future looks promising for diabetic patients.